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perioperative oral decontamination in
patients undergoing major elective surgery
Philip Spreadborough1, Sarah Lort1, Sandro Pasquali2, Matthew Popplewell1, Andrew Owen3, Irene Kreis4,
Olga Tucker2,5, Ravinder S Vohra1,6* and on behalf of the Preventing Postoperative Pneumonia Study Group
and the West Midlands Research CollaborativeAbstract
Background: Oral antiseptics reduce nosocomial infections and ventilator-associated pneumonia in critically ill medical
and surgical patients intubated for prolonged periods. However, the role of oral antiseptics given before and after
planned surgery is not clear. The aim of this systematic review and meta-analysis is to determine the effect of oral
antiseptics (chlorhexidine or povidone–iodine) when administered before and after major elective surgery.
Methods: Searches were conducted of the MEDLINE, EMBASE and Cochrane databases. The analysis was performed
using the random-effects method and the risk ratio (RR) with 95 % confidence interval (CI).
Results: Of 1114 unique identified articles, perioperative chlorhexidine was administered to patients undergoing
elective surgery in four studies. This identified 2265 patients undergoing elective cardiac surgery, of whom 1093
(48.3 %) received perioperative chlorhexidine. Postoperative pneumonia and nosocomial infections were observed in
5.3 and 20.2 % who received chlorhexidine compared to 10.4 and 31.3 % who received a control preparation,
respectively. Oral perioperative chlorhexidine significantly reduced the risk of postoperative pneumonia (RR = 0.52;
95 % CI 0.39–0.71; p < 0.01) and overall nosocomial infections (RR = 0.65; 95 % CI 0.52–0.81; p < 0.01), with no
effect on in-hospital mortality (RR = 1.01; 95 % CI 0.49–2.09; p = 0.98).
Conclusions: Perioperative oral chlorhexidine significantly decreases the incidence of nosocomial infection and
postoperative pneumonia in patients undergoing elective cardiac surgery. There are no randomised controlled
studies of this simple and cheap intervention in patients undergoing elective non-cardiac surgery.
Trial Registration: This systematic review was registered with the International prospective register of systematic
reviews (PROSPERO). The registration number is CRD42015016063.
Keywords: Anti-infective agents, Chlorhexidine, Perioperative care, PneumoniaBackground
An estimated 234 million patients undergo major sur-
gery worldwide every year. Nosocomial infections, par-
ticularly postoperative pneumonia, following surgery
are common, affecting 1.5–57 % of patients depending
on the type and extent of surgery (Weiser et al. 2008;* Correspondence: ravinder.vohra@nuh.nhs.uk
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lowing major elective abdominal surgery, postoperative
pneumonia results in six to nine extra hospital days
and costs the healthcare system an additional $30,000
per patient (Khuri et al. 2005). Even after risk adjust-
ment, it is associated with a 66 % lower survival at
5 years following surgery (Khuri et al. 2005). In those
who do survive, the limited available evidence suggests
a detrimental effect on early and late health-related
quality of life (Thompson et al. 2006).is article is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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the majority of studies is based on clinical, radiological
and microbiological criteria defined by the Center of
Disease Control and Prevention (CDC) for nosocomial
pneumonia between the 2nd and 30th postoperative days
(Garner et al. 1988). One of the primary causes of postop-
erative pneumonia is aspiration of oral and pharyngeal
secretions at the time of intubation before surgery. Con-
tinued micro-aspiration of secretions due to small folds in
the endotracheal tube cuff with prolonged ventilation
(days to weeks) contributes to ventilator-associated pneu-
monia (VAP) (du Moulin et al. 1982; Cook et al. 1998;
American Thoracic Society 2005). Oral antiseptics
such as chlorhexidine gluconate or povidone–iodine
have been shown to reduce the oral bacterial load in
patients mechanically ventilated for 3 days or more.
Chlorhexidine gluconate is a broad-spectrum anti-
microbial, effective against gram-positive and gram-
negative bacteria, anaerobes and fungi within 20 s
(Horner et al. 2012; Fitzgerald et al. 1989). Three re-
cent systematic reviews demonstrate reduction in VAP
by 20 % with regular oral chlorhexidine application
after intubation in critically ill patients mechanically
ventilated for 3 days or more, with conflicting effects
on early mortality (Labeau et al. 2011; Klompas et al.
2014; Price et al. 2014). Recent recommendations sup-
port daily chlorhexidine mouth care to prevent VAP in
the intensive care setting (Scottish Intensive Care Society
Audit Group 2008). However, the majority of elective sur-
gical patients are extubated immediately following surgery
in the operating room. These recommendations of daily
chlorhexidine mouth care do not apply to this group, and
pre-anaesthesia oral decontamination or prophylaxis with
oral antiseptics is currently not part of the routine care.
The aim of this systematic review and meta-analysis is to
determine the effect of oral decontamination using anti-
septics (chlorhexidine or povidone–iodine) before and
after major elective surgery on infective complications and
postoperative mortality.Methods
Study selection
The meta-analysis was performed following the Pre-
ferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines (Moher et al. 2009).
A systematic review was conducted by searching the
MEDLINE, EMBASE and Cochrane databases. The full
search criteria used are included at Appendix A. They
contain search terms used relating to “surgery” and any
combination of “chlorhexidine”, “iodine”, “povidone”
with terms relating to “mouth”, “oral” and “decontam-
ination”. This was limited to a 20-year period between
October 1994 and 2014 and English language publications.All trial designs and interventions (mouthwash, nasal,
gel) were included. Studies in patients under 18 years
and including dental, oral or maxillofacial surgery were
excluded.
Data extraction and synthesis
Two investigators independently reviewed the search
results. A third investigator resolved any disagreements.
Two additional investigators assessed all included pa-
pers. The perioperative period was defined as any time
period before and after the operation. Risk of bias was
assessed using the Cochrane Collaboration checklist
and the Jadad score (Jadad et al. 1996).
Main outcomes and measures
Outcomes assessed were postoperative pneumonia and
overall nosocomial infections, mortality, and intervention-
related adverse events. Postoperative pneumonia was de-
fined as nosocomial pneumonia between the 2nd and 30th
postoperative days based on the CDC criteria (Garner
et al. 1988). Nosocomial infections were defined as sur-
gical site infections and any other infections including
postoperative pneumonia, urinary tract infections and
bacteraemia between the 2nd and 30th postoperative
days (Garner et al. 1988). The additional following in-
formation was sought from all the included papers:
study design, eligibility criteria, randomization method, al-
location method, risk category, strength of solutions used,
treatment regime and number of randomised patients.
Statistical analysis
A meta-analysis methodology was applied to determine
the effect of a perioperative oral antiseptic on the inci-
dence of postoperative pneumonia, nosocomial infections
and mortality following surgery (Higgins and Green 2011).
Data were analysed on an intention-to-treat principle.
When this information was not available, per-protocol
data were used. The outcome measures were the risk ratio
(RR), with 95 % confidence interval (CI), weighted by the
inverse of their variances. In this meta-analysis, mouth-
wash is considered the “experimental” treatment with RR
reported as mouth wash-to-placebo/observation ratios.
We assessed heterogeneity using chi2-based Cochran’s
Q test and I2 statistic tests. Inconsistency across studies
was considered low, moderate and high for I2 statistic
values lower than 25 %, between 25 and 50 % and greater
than 50 %, respectively. Heterogeneity was significant
when the I2 statistic was greater than 50 %, the Cochran’s
Q test p value was smaller than 0.1 or both. A random-
effects model was used to calculate the overall effect.
Results
One thousand six hundred seventy-six articles were identi-
fied (Fig. 1). Five hundred sixty-two duplicates and a
Fig. 1 CONSORT flow diagram of articles included in the systematic review
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was not available for 3 of the 14 remaining abstracts. Four
of the 11 publications met the criteria after full manuscript
review. These studies included 2205 participants of whom
1093 received perioperative chlorhexidine mouthwash or
gel. None of the studies reported iodine use. All four
studies, three randomised controlled and one quasi-
experimental, included patients having elective cardiac
surgery only. Table 1 summarises the sample sizes,
population, intervention regime and outcomes of the
eligible studies. Additional preparations were adminis-
tered in two studies with nasal chlorhexidine gel inTable 1 Summary of sample sizes, population, regime, and outcome
Author Location Patients
(chlorhexidine
vs. control)
Population Chlorhexidine
strength
Regim
De Riso
1996
USA 353 (173 vs. 180) Cardiac 0.12 % Preop
and p
ITU or
Mean
Houston
et al
2002
USA 561 (270 vs. 291) Cardiac 0.12 % Preop
and p
extub
devel
or dea
Nicolosi
et al
2014
Argentina 300 (150 vs. 150) Cardiac 0.12 % Preop
Segers
et al.
2006
USA 991 (500 vs. 491) Cardiac 0.12 % Preop
and p
scaleone, and dental brushing in another. All four studies in-
cluded a placebo (mouthwash, gel or nasal ointment).
All four studies reported postoperative pneumonia rates
and mortality, while three reported nosocomial infection
rates (Segers et al. 2006; DeRiso et al. 1996; Nicolosi et al.
2014). Three studies used intention-to-treat analysis
(DeRiso et al. 1996; Nicolosi et al. 2014; Houston et al.
2002), and one a per-protocol analysis (Segers et al. 2006).
The risk of bias and Jadad scores are summarised in
Table 2. The chlorhexidine regime used varied. All four
studies included preoperative chlorhexidine. Three studies
continued the intervention postoperatively with varyings
e Overall
nosocomial
infection
Postoperative
pneumonia
Mortality
(no time scale given)
ostop (discharge from
death).
= 8.2 days
8/173 (4.6 %)
24/180 (13.3 %)
5/173 (2.9 %)
17/180 (9.4 %)
3/173 (1.7 %)
10/180
(5.6 %)
(no time scale given)
ostop (10 days or
ation, tracheostomy,
opment of POP
th)
– 4/270 (1.5 %)
9/291 (3.1 %)
6/270 (2.2 %)
3/291 (1 %)
(3 days) 46/150 (30.7 %)
69/150 (46 %)
4/150 (2.7 %)
13/150 (8.7 %)
8/150 (5.3 %)
7/150 (4.7 %)
(mean = 1.9 days)
ostop (no time
given)
116/500 (23.2 %)
164/491 (33.4 %)
45/500 (9 %)
74/491
(15.1 %)
8/500 (1.6 %)
6/491 (1.2 %)
Table 2 Risk of bias in studies
Study Random sequence generation Allocation concealment Blinding Incomplete data
outcome addressed
Nicolosi et al. 2014 N/A N/A N/A N/A
Segers et al. 2006 Low risk Low risk Low risk Low risk
Houston et al. 2002 High risk Unclear Unclear Low risk
DeRiso et al. 1996 Low risk Low risk Low risk Low risk
N/A not applicable
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et al. 1996; Houston et al. 2002). Only one study re-
ported duration and dosing (Nicolosi et al. 2014).
Postoperative pneumonia
Three of the four studies used the CDC definition
(American Thoracic Society 2005; Segers et al. 2006;
DeRiso et al. 1996; Houston et al. 2002; Rotstein et al.
2008). Timing of the diagnosis was variable and not re-
ported in one study (Segers et al. 2006; DeRiso et al.
1996; Nicolosi et al. 2014; Houston et al. 2002). Fifty-
eight (5.3 %) patients in the chlorhexidine group devel-
oped postoperative pneumonia compared with 113
(10.2 %) patients in the control group (RR = 0.52; 95 %
CI 0.39–0.71; p < 0.01). There was no statistical signifi-
cant between study heterogeneity (p = 0.45; I2 = 0 %).
This produced a number needed to treat of 14 (Fig. 2).
Nosocomial infections
Of the three studies that reported nosocomial infection
rates, 170 (20.7 %) patients in the chlorhexidine group,
compared with 265 (31.3 %) in the control arm, developed
a nosocomial infection (RR = 0.65; 95 % CI 0.52–0.81; p <
0.01). There was no statistical significant between study
heterogeneity (p = 0.23; I2 = 32 %). This produced a num-
ber needed to treat of 9 (Fig. 3).
Mortality
All four studies reported in-hospital mortality (Fig. 4)
with 25 (2.3 %) deaths in the chlorhexidine group com-
pared with 26 (2.3 %) in the control arm (RR = 1.01; 95 %Fig. 2 Forest plot comparing postoperative pneumonia in patients with or
was used for meta-analysis. Risk ratios are shown with 95 % confidence intCI 0.49–2.09; p = 0.98). There was no statistical significant
between study heterogeneity (p = 0.19; I2 = 37 %).Adverse events
Temporary teeth discolouration was reported in a study,
in 1 of 500 patients (0.2 %) who received chlorhexidine.Discussion
Routine administration of oral chlorhexidine prepara-
tions before and after oral surgery reduces local and
systemic infective complications (Berchier et al. 2010;
Supranoto S et al. 2015; Lambert et al. 1997). This is
the first systematic review to determine the effective-
ness of perioperative oral antiseptic use in patients
undergoing major elective surgery. When administered
both before and after elective cardiac surgery, oral anti-
septic use with chlorhexidine significantly reduces the
incidence of postoperative pneumonia and nosocomial
infections with no effect on early mortality. The previ-
ous meta-analyses and current National Institute for
Health and Care Excellence (NICE) and CDC guide-
lines focus on critically ill patients including emergency
and elective surgical patients mechanically ventilated
for 3 days or more (National Institute for Health and
Care Excellence 2014; Tablan et al. 2004). The meta-
analysis by Labeau et al. demonstrated a significant
reduction in VAP (RR 0.67; 95 % CI 0.50–0.88; p < 0.01)
with oral chlorhexidine or povidone–iodine use (Labeau
et al. 2011). The effect was highest with chlorhexidine (RR
0.72; 95 % CI 0.55–0.94; p = 0.02). A subgroup analysis of
two studies suggested patients undergoing cardiac surgerywithout chlorhexidine cover. A Mantel–Haenszel random-effects model
erval
Fig. 3 Forest plot comparing nosocomial infections in patients with or without chlorhexidine cover. A Mantel–Haenszel random-effects model
was used for meta-analysis. Risk ratios are shown with 95 % confidence interval
Spreadborough et al. Perioperative Medicine  (2016) 5:6 Page 5 of 7might have the greatest benefit from oral antiseptic use
(RR 0.41; 95 % CI 0.17–0.98; p = 0.05) (Labeau et al. 2011).
This systematic review aimed to identify studies in-
vestigating the effectiveness of oral antiseptic use be-
fore and after major elective surgery. No studies were
identified that included patients undergoing elective
non-cardiac surgery or who were administered oral
povidone–iodine.
Even though the number of studies performed is small,
a clear benefit was demonstrated in the reduction of the
incidence of postoperative pneumonia and nosocomial in-
fection with perioperative oral chlorhexidine. Periopera-
tive oral chlorhexidine would need to be administered to
14 patients to prevent one episode of postoperative pneu-
monia and 9 patients to prevent one episode of nosoco-
mial infection. These small numbers needed to treat
further supports the effectiveness of the intervention.
Other approaches, including selective decontamination
of the digestive tract with antibiotics, reduce the incidence
of postoperative pneumonia and nosocomial infection;
however, uptake of this technique is limited by concerns
of emerging antibiotic resistance (Silvestri and van Saene
2010; Nathens and Marshall 1999; Silvestri and van Saene
2012; Bastin and Ryanna 2009). These approaches were
not considered in this systematic review. As the four stud-
ies identified included cardiac patients only the findings
may not be generalisable to non-cardiac surgical cohorts.
Currently, oral chlorhexidine preparations are used to
control dental plaque, treat gingivitis and given rou-
tinely before and after oral surgery to reduce local and
systemic infective complications (Berchier et al. 2010;
Supranoto et al. 2015; Lambert et al. 1997). OutsideFig. 4 Forest plot comparing in-hospital mortality in patients with or witho
used for meta-analysis. Risk ratios are shown with 95 % confidence intervalthis setting, oral chlorhexidine preparations are not
routinely administered in the perioperative setting. A
recent international consensus statement from over
1000 anaesthetists, intensive care specialists, surgeons,
and epidemiologists identified oral chlorhexidine prepara-
tions as an inexpensive intervention that may reduce peri-
operative mortality across surgical disciplines (Landoni
et al. 2012). The expert panel commented that the lack of
availability of effectiveness studies evaluating the use of
perioperative chlorhexidine preparations has in part pre-
vented its widespread adoption (Landoni et al. 2012; Rello
et al. 2007).
Oral chlorhexidine is recommended in patients who
remain intubated for prolonged periods as it is proven
to reduce the incidence of VAP. Perioperative oral
chlorhexidine reduces the incidence of postoperative
pneumonia and nosocomial infections following elect-
ive cardiac surgery. No studies have been performed to
evaluate the effectiveness of perioperative oral chlor-
hexidine on nosocomial infections and postoperative
pneumonia after elective non-cardiac surgery. We sug-
gest that a pragmatic, multi-centre and large clinical
trial is needed to demonstrate the effectiveness of this
simple, well-tolerated, and cheap intervention before
and after elective major non-cardiac surgery before it
will be accepted and introduced into complex peri-
operative clinical care pathways.Conclusions
Perioperative oral chlorhexidine significantly decreases
the incidence of nosocomial infection and postoperativeut chlorhexidine cover. A Mantel–Haenszel random-effects model was
Spreadborough et al. Perioperative Medicine  (2016) 5:6 Page 6 of 7pneumonia in patients undergoing elective cardiac sur-
gery. There are no randomised controlled studies of this
simple and cheap intervention in patients undergoing
elective non-cardiac surgery. Given the low number
needed to treat to prevent either event, we suggest that
this intervention may benefit patients undergoing major
elective non-cardiac surgery, but additional research is
required prior to its routine adoption in perioperative
care pathways.
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